K. Robert Shen

K. Robert Shen

Auto-generated profile, based on publicly available information

K. Robert Shen

Division of General Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minn

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
KSK. Robert Shen
K. Robert Shen
ABAlejandro Bribriesco
Alejandro Bribriesco
TCTraves Crabtree
Traves Crabtree
CDChad Denlinger
Chad Denlinger
JEJoshua Eby
Joshua Eby
BKBenjamin Kozower
Benjamin Kozower

1 September 2010 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
KSK. Robert Shen
K. Robert Shen
MAMark S. Allen
Mark S. Allen
SCStephen D. Cassivi
Stephen D. Cassivi
FNFrancis C. Nichols
Francis C. Nichols
DWDennis A. Wigle
Dennis A. Wigle
CDClaude Deschamps
Claude Deschamps

4 July 2019 in BMC Cancer
Verified
Journal Article
Open access
PDF file
EHEliza Hagens
Eliza Hagens
Mark I. van Berge HenegouwenMark I. van Berge Henegouwen
Mark I. van Berge Henegouwen
JSJohanna W. van Sandick
Johanna W. van Sandick
MCMiguel A. Cuesta
Miguel A. Cuesta
DPDonald L. van der Peet
Donald L. van der Peet
SGSuzanne S. Gisbertz
Suzanne S. Gisbertz
An important parameter for survival in patients with esophageal carcinoma is lymph node status. The distribution of lymph node metastases depends on tumor characteristics such as tumor location, histology, invasion depth, and on neoadjuvant treatment. The exact distribution is unknown. Neoadjuvant treatment and surgical strategy depends on the distribution pattern of nodal metastases but consensus on the extent of lymphadenectomy has not been reached. The aim of this study is to determine the distribution of lymph node metastases in patients with resectable esophageal or gastro-esophageal junction carcinoma in whom a transthoracic esophagectomy with a 2- or 3-field lymphadenectomy is performed. This can be the foundation for a uniform worldwide staging system and establishment of the optimal surgical strategy for esophageal cancer patients. The TIGER study is an international observational cohort study with 50 participating centers. Patients with a resectable esophageal or gastro-esophageal junction carcinoma in whom a transthoracic esophagectomy with a 2- or 3-field lymphadenectomy is performed in participating centers will be included. All lymph node stations will be excised and separately individually analyzed by pathological examination. The aim is to include 5000 patients. The primary endpoint is the distribution of lymph node metastases in esophageal and esophago-gastric junction carcinoma specimens following transthoracic esophagectomy with at least 2-field lymphadenectomy in relation to tumor histology, tumor location, invasion depth, number of lymph nodes and lymph node metastases, pre-operative diagnostics, neo-adjuvant therapy and (disease free) survival. The TIGER study will provide a roadmap of the location of lymph node metastases in relation to tumor histology, tumor location, invasion depth, number of lymph nodes and lymph node metastases, pre-operative diagnostics, neo-adjuvant therapy and survival. Patient-tailored treatment can be developed based on these results, such as the optimal radiation field and extent of lymphadenectomy based on the primary tumor characteristics. NCT03222895 , date of registration: July 19th, 2017.

1 April 2010 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
KSK. Robert Shen
K. Robert Shen
KHKaren M. Harrison-Phipps
Karen M. Harrison-Phipps
SCStephen D. Cassivi
Stephen D. Cassivi
DWDennis Wigle
Dennis Wigle
FNFrancis C. Nichols
Francis C. Nichols
CDClaude Deschamps
Claude Deschamps

1 April 2013 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
CSChristopher W. Seder
Christopher W. Seder
MAMark S. Allen
Mark S. Allen
SCStephen D. Cassivi
Stephen D. Cassivi
CDClaude Deschamps
Claude Deschamps
FNFrancis C. Nichols
Francis C. Nichols
DWDennis A. Wigle
Dennis A. Wigle